Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
1.680
-0.020 (-1.18%)
At close: Dec 5, 2025, 4:00 PM EST
1.690
+0.010 (0.60%)
After-hours: Dec 5, 2025, 7:56 PM EST

Cyclerion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
6882975104
Upgrade
Market Cap Growth
43.55%-0.51%-71.30%-61.69%-28.31%39.09%
Upgrade
Enterprise Value
25-181684
Upgrade
Last Close Price
1.683.223.3513.1234.4061.20
Upgrade
PS Ratio
1.694.08-96.1018.9045.26
Upgrade
PB Ratio
0.650.920.732.731.541.75
Upgrade
P/TBV Ratio
0.670.920.732.731.541.75
Upgrade
EV/Sales Ratio
0.642.64-27.393.9336.37
Upgrade
Debt / Equity Ratio
-----0.77
Upgrade
Asset Turnover
0.300.17-0.010.050.02
Upgrade
Quick Ratio
5.325.233.631.774.883.22
Upgrade
Current Ratio
5.785.833.851.945.003.45
Upgrade
Return on Equity (ROE)
-24.80%-30.36%-115.85%-62.17%-95.87%-98.97%
Upgrade
Return on Assets (ROA)
-23.51%-19.76%-38.34%-29.94%-38.86%-34.34%
Upgrade
Return on Capital (ROIC)
-25.61%-22.52%-55.47%-39.48%-44.24%-37.44%
Upgrade
Return on Capital Employed (ROCE)
-38.10%-41.00%-85.50%-177.40%-112.60%-84.30%
Upgrade
Earnings Yield
-34.39%-37.51%-64.25%-154.44%-69.32%-74.87%
Upgrade
FCF Yield
-21.50%-53.17%-259.37%-142.29%-49.02%-71.22%
Upgrade
Buyback Yield / Dilution
-14.72%-7.70%-7.59%-11.03%-28.75%-11.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.